Thomas Clark Gamblin

Thomas Clark Gamblin

Auto-generated profile, based on publicly available information

Thomas Clark Gamblin

Medical College of Wisconsin

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2014 in Journal of Surgical Oncology
Verified
Journal Article
Closed access
PDF file
LBLucas M. Boehm
Lucas M. Boehm
TJThejus T. Jayakrishnan
Thejus T. Jayakrishnan
JMJohn T. Miura
John T. Miura
AZAnthony J. Zacharias
Anthony J. Zacharias
Fabian M. JohnstonFabian M. Johnston
Fabian M. Johnston
TGT. Clark Gamblin
T. Clark Gamblin

1 August 2017 in HPB
Verified
Journal Article
Closed access
JSJack P. Silva
Jack P. Silva
NBNicholas G. Berger
Nicholas G. Berger
STSusan Tsai
Susan Tsai
KCKathleen K. Christians
Kathleen K. Christians
CCCallisia N. Clarke
Callisia N. Clarke
TGT. Clark Gamblin
T. Clark Gamblin

5 February 2013 in Journal of Surgical Oncology
Verified
Journal Article
Closed access
PDF file
RGRyan T. Groeschl
Ryan T. Groeschl
KTKiran K. Turaga
Kiran K. Turaga
TGT. Clark Gamblin
T. Clark Gamblin

17 March 2015 in Annals of Surgical Oncology
Verified
Journal Article
Closed access
PDF file
JMJohn T. Miura
John T. Miura
Fabian M. JohnstonFabian M. Johnston
Fabian M. Johnston
STSusan Tsai
Susan Tsai
BGBen George
Ben George
JTJim Thomas
Jim Thomas
TGT. Clark Gamblin
T. Clark Gamblin

1 October 2014 in HPB
Verified
Journal Article
Open access
PDF file
JMJohn T. Miura
John T. Miura
AAAlbert Amini
Albert Amini
RSRyan Schmocker
Ryan Schmocker
SNShawnn Nichols
Shawnn Nichols
DSDaniel Sukato
Daniel Sukato
TGT. Clark Gamblin
T. Clark Gamblin
The increasing use of abdominal imaging modalities has resulted in a greater frequency of benign liver tumours being identified annually. Hepatic hemangiomas are the most common neoplasm of the liver, with an estimated prevalence of 3% to 20%.1 x 1 Choi, B.Y. and Nguyen, M.H. The diagnosis and management of benign hepatic tumors. J Clin Gastroenterol. 2005; 39: 401–412 Crossref | PubMed | Scopus (14) | Google Scholar See all References The development of hemangiomas remains poorly understood; however, studies have suggested oestrogen exposure as a potential pathophysiological mechanism.2 x 2 Glinkova, V., Shevah, O., Boaz, M., Levine, A., and Shirin, H. Hepatic haemangiomas: possible association with female sex hormones. Gut. 2004; 53: 1352–1355 Crossref | PubMed | Scopus (72) | Google Scholar See all References , 3 x 3 Cobey, F.C. and Salem, R.R. A review of liver masses in pregnancy and a proposed algorithm for their diagnosis and management. Am J Surg. 2004; 187: 181–191 Abstract | Full Text | Full Text PDF | PubMed | Scopus (101) | Google Scholar See all References Enlargement of these lesions follows an ectatic growth pattern rather than through neoplasia. Grossly, hemangiomas are well-circumscribed and compressible lesions. Histologically, multiple blood vessels lined by endothelial cells are present.4 x 4 Mergo, P.J. and Ros, P.R. Benign lesions of the liver. Radiol Clin North Am. 1998; 36: 319–331 Abstract | Full Text | Full Text PDF | PubMed | Scopus (114) | Google Scholar See all References In spite of the absent risk of malignant transformation and otherwise benign clinical course, a uniform management approach for hepatic hemangiomas is lacking.

21 August 2014 in World Journal of Surgical Oncology
Verified
Journal Article
Open access
PDF file
Thejus JayakrishnanThejus Jayakrishnan
Thejus Jayakrishnan
AZAnthony J Zacharias
Anthony J Zacharias
ASAvishkar Sharma
Avishkar Sharma
SPSam G Pappas
Sam G Pappas
TGT Clark Gamblin
T Clark Gamblin
KTKiran K Turaga
Kiran K Turaga
We hypothesized that diagnostic laparoscopy (DL) was feasible for the evaluation of patients with peritoneal carcinomatosis (PC) undergoing cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CRS + HIPEC). A retrospective review of PC patients treated from January 2010 to April 2013 was conducted. Data on tumor characteristics, treatment details and survival outcomes were extracted and analyzed. Of the 101 PC patients (mean age 52.9 ± 14.1 years), 73 diagnostic laparoscopies DL (61 concurrent with CRS + HIPEC) were performed in 70 patients whereas 31 patients underwent direct exploratory laparotomy (EL). Complete laparoscopic assessment was possible in 63 cases (86.3%), resulting in 18 exclusions (27.7%) while 10 cases were converted to open due to inadequate laparoscopic visualization. Subsequently, CRS + HIPEC was performed in 85.4% (of 55 selected for HIPEC, DL) versus 74.2% (EL, P value = 0.20). Among those excluded from HIPEC at the initial operation, delayed HIPEC after conversion chemotherapy was achieved in 6 (of 11 with extensive disease, DL). The incidence of grade 3 to 5 complications was 0% DL versus 10% EL (P value = 0.2). There were no port site recurrences at mean follow up of 9.1 ± 8 months. Laparoscopy is a feasible technique for selecting patients with PC for CRS + HIPEC, and can help select patients for conversion chemotherapy in the setting of high peritoneal carcinomatosis index (PCI) score.